NIPOCALIMAB DEMONSTRATES SUSTAINED DISEASE CONTROL IN ADOLESCENTS LIVING WITH GENERALIZED MYASTHENIA GRAVIS IN PHASE 2/3 STUDY

Reuters · 10/15 12:00

Please log in to view news